Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Fampyra launched in Canada

April 12, 2012

Lilly obtains approval in Canada for testosterone replacement therapy

April 12, 2012

Biovest to file marketing application in Canada

April 11, 2012

Health Canada approves grass pollen immunotherapy

March 22, 2012

Health Canada approves diclofenac therapy

March 19, 2012

NDS for insomnia therapy accepted for review by Health Canada

Feb. 23, 2012

Roche obtains Canadian approval for Zelboraf

Feb. 17, 2012

Health Canada approves line extension for Prevnar 13

Feb. 17, 2012

RedHill Biopharma clear to conduct advanced-stage RHB-102 trial

Feb. 15, 2012

RedHill receives approval from Health Canada to begin RHB-102 trial

Feb. 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...